Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 33 - Antiparasitic agents
Patents for A61P 33 - Antiparasitic agents (21,787)
12/1999
12/28/1999US6007825 Serpulina hyodysenteriae vaccine comprising a tly gene mutant
12/23/1999WO1999065933A1 Novel cyclosporins
12/23/1999WO1999065886A1 Benzazole compounds and their use
12/23/1999WO1999065867A1 Cyclic hydroxamic acids as metalloproteinase inhibitors
12/23/1999WO1999065505A1 Oregano for the treatment of internal parasites and protozoa
12/23/1999WO1999065311A1 Composition for keeping away vermin
12/23/1999CA2333554A1 Cyclic hydroxamic acids as metalloproteinase inhibitors
12/23/1999CA2330977A1 Benzazole compounds and their use
12/23/1999CA2329932A1 Composition for keeping away vermin
12/22/1999CN1238987A Chinese medicine for treating digestive tract inflammation and ulcer
12/22/1999CN1238950A Compound antimalarial medicine containing artemisine medicines and malaridine
12/21/1999CA1340858C Recombinant and native group b eimeria tenella immunogens useful as coccidiosis vaccines
12/16/1999WO1999064464A2 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means
12/16/1999WO1999064423A1 Furopyridine derivatives and their therapeutical use
12/16/1999WO1999064021A1 hCEPR RECEPTOR
12/16/1999WO1999063824A2 Control of parasitic infestations in farmed and wild fish
12/16/1999CA2333629A1 Furopyridine derivatives and their therapeutical use
12/15/1999EP0963198A1 ANTI-PARASITIC ACTION OF N,N-DIETHYL-m-TOLUAMIDE (DEET) AND FORMULATIONS THAT PROLONG ITS ACTIVITY IN THE SKIN
12/15/1999EP0788366B1 Use of 2'-substituted oligonucleotides to down-regulating gene expression
12/15/1999EP0664703B1 Methods of combating (pneumocystis carinii) pneumonia and compounds useful therefor
12/15/1999CN1238696A Vaccines
12/14/1999US6001363 Eimeria protein with immunogenic properties; dna encoding this protein can be used for the preparation of a vector vaccine against coccidiosis
12/09/1999WO1999062519A1 Semi-solid aqueous preparations for oral applications of toltrazuril sulphone
12/09/1999WO1999052938A3 Identification of chemical active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway in parasites
12/09/1999WO1999051264A3 Leishmania cysteine proteinases
12/09/1999DE19824483A1 Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon Semi-solid aqueous preparations for oral administration of toltrazuril sulfone
12/08/1999EP0961779A1 SUBSTITUTED AMINO BICYCLIC-$g(b)-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS
12/08/1999EP0961775A2 Purine l-nucleosides, analogs and uses thereof
12/08/1999CN1237416A Compound piperaquine tablet
12/07/1999US5998476 Reaction product of unsaturated fatty acid with glycine or aspartic acid
12/07/1999US5998449 Malaria
12/07/1999US5998447 Heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
12/07/1999CA1340839C Proteins and process for preparing them, dna sequences, antibodies and uses thereof, posvirus, altered or infected cells, pharmaceutical compositions useful for the prevention of schistosomosis and uses thereof as an agent with a glutathion-s-transferase activity
12/07/1999CA1340838C Coccidiosis vacine
12/02/1999WO1999061471A2 Human transmembrane proteins
12/02/1999WO1999061440A1 Novel substituted imidazole compounds
12/02/1999WO1999061437A1 Novel 2-alkyl substituted imidazole compounds
12/02/1999WO1999061427A1 N-substituted derivatives of 5-oxyiminobarbituric acid
12/02/1999WO1999061426A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
12/02/1999WO1999051745A3 Dna immunization against chlamydia infection
12/02/1999CA2333537A1 N-substituted derivatives of 5-oxyiminobarbituric acid
12/02/1999CA2333157A1 Novel substituted imidazole compounds
12/02/1999CA2332459A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
12/02/1999CA2332402A1 Novel 2-alkyl substituted imidazole compounds
12/02/1999CA2329072A1 Human transmembrane proteins
12/01/1999CN1046943C Potycyclic antiparasitic agent, its process and composition containing same
12/01/1999CN1046852C Process for preparing microspheroidal composition for non-enterogastric area of warm blooded animal
11/1999
11/30/1999US5994395 Composition for controlling parasites
11/30/1999US5994098 G protein coupled receptor gene; treatment of pain, diabetes, eating disorders, asthma; hypotensive/hypertensive agents; parkinson's/huntington's/cardiovascular diseases, ulcers, anticarcinogenic/antiallergens agents; osteoprosis,
11/30/1999US5993827 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
11/30/1999US5993811 Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis
11/25/1999WO1999060015A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
11/25/1999WO1999059981A1 Thermally stable trimetrexates and processes for producing the same
11/25/1999CA2333274A1 Thermally stable trimetrexates and processes for producing the same
11/25/1999CA2331875A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
11/24/1999EP0959071A1 1-Aryl-4-cycloalk(en)ylpyrazoles as antiparasitic agents
11/24/1999EP0958366A1 Human chemokine beta-13
11/24/1999EP0957933A1 Vaccine composition against malaria
11/24/1999CN1236391A Method for producing recombinants intended for use in a complete malaria antigene gp 190/MSP1
11/24/1999CN1236012A Polycyclic antiparasitic agents, process and strain for their preparation and their use
11/24/1999CN1235826A 10, 11 methanodibenzosuberane derivatives used as chemosensitizing agents
11/18/1999WO1999058528A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999WO1999058523A1 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
11/18/1999DE19821483A1 New imidazolidine derivatives useful as leukocyte adhesion and migration inhibitors and/or VLA-4 receptor antagonists for treating E.G. inflammatory and allergic disorders
11/18/1999CA2331878A1 1,5-diaryl substituted pyrazoles as p38 kinase inhibitors
11/18/1999CA2330095A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/17/1999EP0957094A1 1-(2-Halogenaryl)azoles as antiparasitic agents
11/17/1999EP0956040A1 Stimulation of host defense mechanisms against viral challenges
11/17/1999EP0572537B1 Cytokine inhibitors
11/17/1999CN1235609A Immunostimulatory nucleic acid molecules
11/17/1999CN1235164A Peptide for vaccine of schistosomiasis
11/17/1999CN1235163A Peptide for vaccine of schistosomiasis
11/17/1999CN1235035A Medicine and prescription for toxoplasmic disease
11/17/1999CN1234976A Method for extracting sulphur containing part from garlic and preparation of oil containing sulphur part
11/17/1999CN1046535C Erythromycin A 9-0-oxime derivatives endowed with antibiotic activity and their medicinal compositions
11/16/1999US5985935 Treatment and prophylaxis of diseases caused by parasites, or bacteria
11/16/1999US5985848 Inhibitors of nucleoside metabolism
11/16/1999US5984887 Photopheresis treatment of leukocytes
11/11/1999WO1999057271A2 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides
11/11/1999WO1999057125A2 Hygromycin a derivatives
11/11/1999WO1999056755A1 Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides
11/11/1999WO1999045016A9 Novel prodrugs for phosphorus-containing compounds
11/11/1999CA2328602A1 Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides
11/11/1999CA2327539A1 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides
11/10/1999CN1234742A Improvements in or relating to diagnostic/therapeutic agents and improvement relating to same
11/10/1999CN1234226A Mite-killing face-beauty cream
11/10/1999CN1046271C Substituted pyrimidines and fungicidal and pesticidal and anti-septic composition containing same
11/09/1999US5981494 Administering to the mammal a glycosidase inhibitor to inhibit the conversion of pro-toxin to toxin which causes maleria, endotoxic shock or septic shock in mammals
11/09/1999US5981479 Administering to the aids patient a nonimmunosuppressive, cyclophilin-bining cyclosporin which binds to human genetic engineered cyclophilin and has an activity in the mixed lymphocyte reaction of not more than 10% that of ciclosporin
11/09/1999US5981277 Polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
11/09/1999US5980915 Administering an antiprotozoa agent
11/04/1999WO1999055316A2 Kinase obtained from leishmania
11/03/1999EP0953641A2 Polynucleotide molecules encoding neospora proteins
11/03/1999CN1233936A Method for the prevention of reinfestation of warm-blooded animals by ectoparasisites
11/02/1999US5976814 DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof
11/02/1999US5976553 Transfection and genetic manipulations in obligate intracellular parasites
10/1999
10/28/1999WO1999054351A1 Edg family gene, human h218
10/28/1999WO1999029341A3 Methods for enhancement of protective immume responses employing leishmania polypeptides
10/27/1999EP0952157A1 9A, 11B-Dehydro derivatives of 9-oxime-3-keto-6-0-methylerythromycin
10/27/1999EP0951299A1 Method of producing active immunity with vaccine conjugate
1 ... 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 ... 218